Yuriy Gusev
Yuriy Gusev
Associate Professor, Innovation Center for Biomedical Informatics, Georgetown University
Adresse e-mail validée de - Page d'accueil
Citée par
Citée par
Expression profiling identifies microRNA signature in pancreatic cancer
EJ Lee, Y Gusev, J Jiang, GJ Nuovo, MR Lerner, WL Frankel, DL Morgan, ...
International journal of cancer 120 (5), 1046-1054, 2007
Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival
J Jiang, Y Gusev, I Aderca, TA Mettler, DM Nagorney, DJ Brackett, ...
Clinical cancer research 14 (2), 419-427, 2008
Real-time expression profiling of microRNA precursors in human cancer cell lines
J Jiang, EJ Lee, Y Gusev, TD Schmittgen
Nucleic acids research 33 (17), 5394-5403, 2005
A community effort to assess and improve drug sensitivity prediction algorithms
JC Costello, et all
Nature Biotechnology, 2014
Systematic evaluation of microRNA processing patterns in tissues, cell lines, and tumors
EJ Lee, M Baek, Y Gusev, DJ Brackett, GJ Nuovo, TD Schmittgen
Rna 14 (1), 35-42, 2008
miR-132 and miR-212 are increased in pancreatic cancer and target the retinoblastoma tumor suppressor
JK Park, JC Henry, J Jiang, C Esau, Y Gusev, MR Lerner, RG Postier, ...
Biochemical and biophysical research communications 406 (4), 518-523, 2011
Association between extent of axillary lymph node dissection and survival in patients with stage I breast cancer
JA Sosa, M Diener-West, Y Gusev, MA Choti, JR Lange, WC Dooley, ...
Annals of surgical oncology 5 (2), 140-149, 1998
Rolling circle amplification: a new approach to increase sensitivity for immunohistochemistry and flow cytometry
Y Gusev, J Sparkowski, A Raghunathan, H Ferguson Jr, J Montano, ...
The American journal of pathology 159 (1), 63-69, 2001
Tumor suppressive function of mir-205 in breast cancer is linked to HMGB3 regulation
OA Elgamal, JK Park, Y Gusev, ACP Azevedo-Pouly, J Jiang, A Roopra, ...
PloS one 8 (10), e76402, 2013
Computational methods for analysis of cellular functions and pathways collectively targeted by differentially expressed microRNA
Y Gusev
Methods 44 (1), 61-72, 2008
The REMBRANDT study, a large collection of genomic data from brain cancer patients
Y Gusev, K Bhuvaneshwar, L Song, JC Zenklusen, H Fine, S Madhavan
Nature Scientific Data 5, 2018
Computational analysis of biological functions and pathways collectively targeted by co-expressed microRNAs in cancer
Y Gusev, TD Schmittgen, M Lerner, R Postier, D Brackett
BMC bioinformatics 8 (7), 1-17, 2007
Thyroid-specific expression of cholera toxin A1 subunit causes thyroid hyperplasia and hyperthyroidism in transgenic mice
MA Zeiger, M Saji, Y Gusev, WH Westra, Y Takiyama, WC Dooley, ...
Endocrinology 138 (8), 3133-3140, 1997
βII-spectrin (SPTBN1) suppresses progression of hepatocellular carcinoma and wnt signaling via regulation of wnt inhibitor kallistatin
ARH Xiuling Zhi, Ling Lin, Shaoxian Yang, Krithika Bhuvaneshwar, Hongkun ...
Hepatology, 2014
Biomarker identification in human pancreatic cancer sera
JS Hanas, JR Hocker, JY Cheung, JL Larabee, MR Lerner, SA Lightfoot, ...
Pancreas 36 (1), 61-69, 2008
G-DOC: a systems medicine platform for personalized oncology
S Madhavan, Y Gusev, M Harris, DM Tanenbaum, R Gauba, ...
Neoplasia 13 (9), 771-783, 2011
ERRγ target genes are poor prognostic factors in Tamoxifen-treated breast cancer
S Madhavan, Y Gusev, S Singh, RB Riggins
Journal of experimental & clinical cancer research 34 (1), 1-8, 2015
Distinct lymphocyte antigens 6 (Ly6) family members Ly6D, Ly6E, Ly6K and Ly6H drive tumorigenesis and clinical outcome
L Luo, P McGarvey, S Madhavan, R Kumar, Y Gusev, G Upadhyay
Oncotarget, 2016
MicroRNAs are mediators of androgen action in prostate and muscle
R Narayanan, J Jiang, Y Gusev, A Jones, JD Kearbey, DD Miller, ...
PloS one 5 (10), e13637, 2010
Ly6E/K signaling to TGF-ß promotes breast cancer progression, immune escape and drug resistance
MA Hossiny, L Luo, WR Frazier, N Steiner, Y Gusev, B Kallakury, ...
Cancer Research, 2016
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20